Выпуск №4-98, 2020

Lung Pathology in Patients with Acute Respiratory Distress Syndrome Associated with the Novel SARS-Cov-2 Virus

¹ Barberán J., ² Ortiz G., ³ Cardinal-Fernández P.

¹ HM Monteprincipe University Hospital, San Pablo CEU University. Madrid, Spain
² Universidad del Bosque. Bogotá, Colombia
³ HM Sanchinarro University Hospital, HM International Department. Madrid, Spain

РЕЗЮМЕ

Acute Respiratory Distress Syndrome (ARDS) is a well-recognized clinical problem first described in the late sixties. However,its relevance seems to have increased since the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) outbreak,as 14% (CI 95% 2% to 59%) of patients admitted to the hospital present with this syndrome.Conceptually, a syndrome is a group of symptoms and signs that correspond to several diseases. Although defining diseaseis much harder than may appear at first glance, we can view it as the association between a syndrome and a pathologypattern. Diffuse alveolar damage (DAD) is the morphological hallmark of ARDS, although studies performed inautopsies and patients have demonstrated that it is present in only half of ARDS patients. The SARS-CoV-2 outbreak andthe high incidence of ARDS associated with this infection have triggered a natural question: is the lung pathology similarin patients with ARDS associated with traditional risk factors than to SARS-CoV-2 infection?This review aims to analyze the lung pathology results of patients infected with the novel SARS-Cov-2. As this article targetsnon-intensive care physicians, we will first describe the main characteristics of the novel SARS-Cov-2 and the ARDSdefinition, and then the lung pathology results from the UCI in this group of patients.

КЛЮЧЕВЫЕ СЛОВА: coronavirus, SARS-Cov-2 infection, lung pathology, acute respiratory distress syndrome

Для цитирования: Barberán J., Ortiz G., Cardinal-Fernández P. Lung Pathology in Patients with Acute Respiratory Distress Syndrome Associated with the Novel SARS-Cov-2 Virus. Bulletin of Rehabilitation Medicine. 2020; 4 (98): 109–113. https://doi.org/10.38025/2078-1962-2020-98-4-109-113

Список литературы:

1. Ashbaugh D.G., Bigelow D.B., Petty T.L., Levine B.E. Acute respiratory distress in adults. Lancet. 1967; 2(7511): 319-323.
2. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. The New England Journal of Medicine. 2005; 353(16): 1685-1693.
3. Potere N., Valeriani E., Candeloro M., Tana M., Porreca E., Abbate A., et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Critical Care. 2020; 24(1): 389 p.
4. Cardinal-Fernandez P., Correger E., Villanueva J., Rios F. Acute Respiratory Distress: from syndrome to disease. Medicina Intensiva. 2016; 40(3): 169-175.
5. Katzenstein A.L., Bloor C.M., Leibow A.A. Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. The American Journal of Pathology. 1976; 85(1): 209-228.
6. Force A.D.T., Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23): 2526-2533.
7. Cardinal-Fernandez P., Bajwa E.K., Dominguez-Calvo A., Menendez J.M., Papazian L., Thompson B.T. The Presence of Diffuse Alveolar Damage on Open Lung Biopsy Is Associated With Mortality in Patients With Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Chest. 2016; 149(5): 1155-1164.
8. Cardinal-Fernandez P., Ortiz G., Chang C.H., Kao K.C., Bertreau E., Philipponnet C., et al. Predicting the Impact of Diffuse Alveolar Damage through Open Lung Biopsy in Acute Respiratory Distress Syndrome-The PREDATOR Study. Journal of Clinical Medicine. 2019; 8(6).
9. Zumla A., Chan J.F., Azhar E.I., Hui D.S., Yuen K.Y. Coronaviruses - drug discovery and therapeutic options. Nature Reviews Drug Discovery. 2016; 15(5): 327-347.
10. Mohanty S.K., Satapathy A., Naidu M.M., Mukhopadhyay S., Sharma S., Barton L.M., et al. Severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) and coronavirus disease 19 (COV-ID-19) - anatomic pathology perspective on current knowledge. Diagnostic Pathology. 2020; 15(1): 103 p.
11. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798): 270-273.
12. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020.
13. Ferguson N.D., Fan E., Camporota L., Antonelli M., Anzueto A., Beale R., et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Medicine. 2012; 38(10): 1573-1582.
14. Forel J.M., Guervilly C., Hraiech S., Voillet F., Thomas G., Somma C., et al. Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Medicine. 2015; 41(1): 1-11.
15. Lorente J.A., Cardinal-Fernandez P., Munoz D., Frutos-Vivar F., Thille A.W., Jaramillo C., et al. Acute respiratory distress syndrome in patients with and without diffuse alveolar damage: an autopsy study. Intensive Care Medicine. 2015; 41(11): 1921-1930.
16. Rios F., Iscar T., Cardinal-Fernandez P. What every intensivist should know about acute respiratory distress syndrome and diffuse alveolar damage. The Revista Brasileira de Terapia Intensiva. 2017; 29(3):354-363.
17. Cardinal-Fernandez P., Lorente J.A., Ballen-Barragan A., Matute-Bello G. Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage. New Insights on a Complex Relationship. Annals of the American Thoracic Society. 2017; 14(6): 844-850.
18. Cardinal-Fernandez P., Esteban A., Thompson B.T., Lorente J.A. ARDS: lessons learned from the heart. Chest. 2015; 147(1): 7-8.
19. Magro C., Mulvey J.J., Berlin D., Nuovo G., Salvatore S., Harp J., et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COV-ID-19 infection: A report of five cases. Translational Research. 2020; (220): 1-13.
20. Menter T., Haslbauer J.D., Nienhold R., Savic S., Hopfer H., Deigendesch N., et al. Postmortem examination of COV-ID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020.
21. Barnes B.J., Adrover J.M., Baxter-Stoltzfus A., Borczuk A., Cools-Lartigue J., Crawford J.M., et al. Targeting potential drivers of COV-ID-19: Neutrophil extracellular traps. Journal of Experimental Medicine. 2020; 217(6).
22. Rothberg M.B., Haessler S.D. Complications of seasonal and pandemic influenza. Critical Care Medicine. 2010; 38(S.4): e91-7.
23. Liao S.C., Shao S.C., Chen Y.T., Chen Y.C., Hung M.J. Incidence and mortality of pulmonary embolism in COV-ID-19: a systematic review and meta-analysis. Critical Care. 2020; 24(1): 464 p.
24. Fogarty H., Townsend L., Ni Cheallaigh C., Bergin C., Martin-Loeches I., Browne P., et al. More on COV-ID-19 coagulopathy in Caucasian patients. British Journal of Haematology. 2020; 189(6): 1060-1061.
25. Carsana L., Sonzogni A., Nasr A., Rossi R.S., Pellegrinelli A., Zerbi P., et al. Pulmonary post-mortem findings in a series of COV-ID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases. 2020.
26. Fox S.E., Akmatbekov A., Harbert J.L., Li G., Quincy Brown J., Vander Heide R.S. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. The Lancet Respiratory Medicine. 2020; 8(7): 681-686.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.